Industry Partner News: Capricor Announces Licensing of Additional Patent Applications from Cedars-Sinai Medical Center for Cellular and Exosome-based Technologies


Capricor Therapeutics announced January 16th, 2018 that it has added seven new patent applications to its existing Exclusive License Agreements with Cedars-Sinai Medical Center for technologies related to cardiosphere-derived cells (CDCs) and CDC-derived extracellular vesicles, including exosomes. 

These new patent applications will pave the way for Capricor to develop new therapeutic platforms for Duchenne muscular dystrophy and other disorders. 

Read their full release by clicking here.

Capricor Image.jpg